It is important that as our committee crafts legislation on the opioid crisis, we give FDA clear authority to consider potential misuse and abuse of a product.
Gene Green
The Public Record
Gene Green is a former Democratic member of the United States House of Representatives, representing Texas's 29th congressional district from 1993 to 2019. During his tenure, he focused on issues such as healthcare, education, and environmental protection. Green was known for his advocacy for the direct popular vote in presidential elections and for consumer privacy rights in the digital age. He played a significant role in various legislative efforts aimed at improving the lives of his constituents and addressing national concerns.
The opioid epidemic is complex and multifaceted, as you said. However, there are no simple or quick solutions.
Ending this crisis will require better coordination of care, community involvement in finding solutions, and more consistent use of improved pain-control options.
I have a number of statements that I would like to ask unanimous consent to place into the record.
Would you work with us on legislation to ensure that we do not impede or inhibit or otherwise disincentivize research?
While I want to ensure that we are properly protecting against abuse, misuse, and diversion of synthetic substances, I also want to ensure that we are not unintentionally restricting the ability of researchers and drug developers to…
The pattern of lives ruined and lost due to the opioids epidemic must be reversed.
Budgets are more than a numbers on a page--they are a statement of priorities.
I would hope that the administration would not cut the subsidies that some of my working poor...
Does the administration not comprehend the danger of cutting these health insurance programs, and do you agree that people have access to needed healthcare services through that service covered by their insurance?
Unfortunately, I believe the priorities of this administration are wildly out of whack.
Cutting $500 billion in Medicare and more than $1.4 trillion in Medicaid is just not what I think a Health and Human Services Agency ought to be doing.
With all due respect, it's clear that the budget proposal--we fundamentally do not share the same goals.
This dangerous budget imperils access to care for millions of Americans and puts our Nation's healthcare system at risk.
My goal is not to have rationed care, and I think that's probably the goal all of us ought to share as Americans, because my goal has been to expand access.
But that's a congressional decision, both the House and the Senate, and I would hope the agency would not make decisions on it before it gets guidance from Congress...
Proposing to cut Medicaid by $1.4 trillion is an assault on the working families.
Unfortunately, I believe the priorities of the administration are out of whack.
In 2012, the interstate distribution of contaminated compounded drug products led to an outbreak of fungal meningitis in 20 states, which tragically resulted in 64 deaths and left 750 people with infections that were often severe and cause…
Patients' ability to timely access safe compound drugs is vital, and pursuit of this goal is something I believe we all share.
While I believe the FDA dropped the ball with regards to the NECC, with this law they must succeed where in the past they failed.
The Drug Quality and Security Act leaves a large portion of existing law intact. It also leaves many areas of practice where clarification may still be needed.
I say, that is not a Texas value, if we can sell it to someone or build a plant.
The issue of high drug costs is not a simple challenge with a simple solution.
Too many Americans face real barriers in accessing the medications they need.





